Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Clinical Pharmacology
|
March 12, 2021
Nonmedical use of prescription drugs
Serge Cremers, Daniel F B Wright
British Journal of Clinical Pharmacology
|
March 8, 2022
Perspectives on the past, present, and future of pharmacometrics
Robert R Bies, Daniel F B Wright
Clinical Pharmacokinetics
|
January 19, 2013
A Bayesian dose-individualization method for warfarin
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
April 19, 2017
A general empirical model for renal drug handling in pharmacokinetic analyses
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
July 21, 2010
The 'apparent clearance' of free phenytoin in elderly vs. younger adults
Daniel F B Wright, Evan J Begg
British Journal of Clinical Pharmacology
|
September 17, 2013
What do we learn from repeated population analyses?
Stephen B Duffull, Daniel F B Wright
Pharmaceutical Research
|
February 9, 2011
Development of a bayesian forecasting method for warfarin dose individualization
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
July 23, 2021
Science fiction has become reality: Best practice for future viral pandemics
Daniel F B Wright, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology
|
August 29, 2020
Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted
Sudeep Pradhan, Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Clinical Pharmacology
|
March 12, 2021
Nonmedical use of prescription drugs
Serge Cremers, Daniel F B Wright
British Journal of Clinical Pharmacology
|
March 8, 2022
Perspectives on the past, present, and future of pharmacometrics
Robert R Bies, Daniel F B Wright
Clinical Pharmacokinetics
|
January 19, 2013
A Bayesian dose-individualization method for warfarin
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
April 19, 2017
A general empirical model for renal drug handling in pharmacokinetic analyses
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
July 21, 2010
The 'apparent clearance' of free phenytoin in elderly vs. younger adults
Daniel F B Wright, Evan J Begg
British Journal of Clinical Pharmacology
|
September 17, 2013
What do we learn from repeated population analyses?
Stephen B Duffull, Daniel F B Wright
Pharmaceutical Research
|
February 9, 2011
Development of a bayesian forecasting method for warfarin dose individualization
Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
July 23, 2021
Science fiction has become reality: Best practice for future viral pandemics
Daniel F B Wright, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology
|
August 29, 2020
Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted
Sudeep Pradhan, Daniel F B Wright, Stephen B Duffull
British Journal of Clinical Pharmacology
|
November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Page
of 8